LILRB4 and cancer: LILRB4 is expressed on a number of cancers, including AML, multiple myeloma, gastric cancer, melanoma, colorectal, pancreatic, hepatocellular, NSCLC and ovarian cancers (119, 158, 158, 185, 191–196, 290).